News Focus
News Focus
icon url

Drugdoctor

03/16/13 12:50 PM

#48648 RE: dr_lowenstein #48647

But it is insignificant and meaningless, as ELTP is going to launch 3 drugs in the near future and going to have a large infusion of cash to finish their studies and bring to market drugs that may be worth billions of dollars on the market. Let's focus on the positives here, the compensation of the insiders is old news.
icon url

ChicagoIrish34

03/18/13 10:25 AM

#48692 RE: dr_lowenstein #48647

Once again, it does not matter that you were "right" on this issue - focusing on that is missing the forest for the trees. The key points in this compensation conversation are:

- The Chairman and CEO, who should have 2 salaries for his 2 positions, takes NO cash salary, and is only paid in stock.

- The CFO makes a paltry cash salary for his level position and is paid the rest in stock

- The COO makes a slightly higher but still paltry salary for his level position and gets the rest in stock.

- The entire board of directors takes NO salary or cash retainer (unheard of) and is paid a retainer entirely in stock.

This is all a tremendous and unconditional level of support from the people running the company, who only make any real money if the companyt and share price grow

This is an enourmously positive sign for stockholers.